About us

    HISTORY

    2018
    • 09
      • Patent application for Edarabon precursor. (No. 10-2018-0111079).
    2016
    • 08
      • Factory Expansion and Renovation
    2015
    • 12
      • Achieved 60 billion Won in sales
    2012
    • 11
      • Yuhan invested in Theragen Etex
    2010
    • 07
      • Company name was changed to THERAGEN ETEX CO., LTD.
    2004
    • 05
      • Listed on Korean stock market(KOSDAQ)
    1997
    • 09
      • Merged from Bristol-Myers Squibb – Qualified for KGMP
    • 08
      • ETEX Pharmaceuticals Korea was founded
    1987
    • 04
      • Predecessor establishment of LEADPHARM
    • 03
      • Established Essel-Tech. (Predecessor of Theragen)